Macopharma is excited to renew its Corporate Partnership with AABB for 2023

We are pleased to announce that Macopharma is renewing the AABB corporate partnership program.

Roxane Smith, our country manager in USA  is sharing her views on the partnership : “The AABB Corporate Partnership Program is a great way for Macopharma to show our support for the industry (blood and biotherapy)and to be closely connected to AABB members.
As a Corporate Partner, we were excited to submit and receive SCoPE certification for Macopharma’s MacoPress Smarter, our Automated Wole Blood Component Separator.  We are excited to participate in the NBF (now AABB Foundation) and to be a part of those important discussions about the future of our industry.
We appreciate the availability of our Account Executive, Margie Boraz, who has guided us to ‘Ask The Expert’ and other important AABB meetings which allow us to learn and share.
Macopharma is excited to renew our Corporate Partnership with AABB for 2023.“